Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Meyerhardt, Jeffrey
Item TypeName
Academic Article Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
Academic Article Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence.
Academic Article Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.
Academic Article Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
Academic Article Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Academic Article Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.
Academic Article Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
Academic Article Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803.
Academic Article Adjuvant Therapy in Gastric Cancer: Can We Prevent Recurrences?
Academic Article Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
Academic Article Impact of diabetes mellitus on outcomes in patients with colon cancer.
Academic Article The role of obesity in cancer survival and recurrence.
Academic Article Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.
Academic Article Adjuvant therapy in gastric cancer: can we prevent recurrences?
Academic Article Follow-up strategies after curative resection of colorectal cancer.
Academic Article New developments in the adjuvant therapy of stage II colon cancer. Risk assessments in the older patient.
Academic Article Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.
Academic Article The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803.
Academic Article Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
Academic Article Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
Academic Article Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer.
Academic Article Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy?
Academic Article Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Academic Article Impact of hospital volume on recurrence and survival after surgery for gastric cancer.
Academic Article The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803
Concept Neoplasm Recurrence, Local
Concept Recurrence
Academic Article The impact of glycemic levels in patients with colon cancer.
Academic Article Patterns of physical activity participation across the cancer trajectory in colorectal cancer survivors.
Academic Article Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance.
Academic Article Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance).
Academic Article Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.
Academic Article Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
Grant Predictors of Outcome in Colorectal Cancer
Academic Article KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803.
Academic Article The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803.
Academic Article Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance).
Academic Article Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).
Academic Article Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
Academic Article Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
Academic Article Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
Academic Article Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Academic Article Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance).
Academic Article Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Academic Article Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance).
Academic Article Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance).
Academic Article Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline.
Search Criteria
  • Recurrence
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.